Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BNT314 |
Trade Name | |
Synonyms | BNT 314|BNT-314|GEN1059|GEN 1059|GEN-1059 |
Drug Descriptions |
BNT314 (GEN1059) is a bispecific antibody targeting TNFRSF9 (4-1BB) and EpCAM, which potentially induces antitumor immune activity (Ann Oncol (2023) 34 (suppl_2): S619-S650). |
DrugClasses | TNFRSF9 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BNT314 | BNT314 | 0 | 1 |
BNT314 + Pembrolizumab | BNT314 Pembrolizumab | 0 | 1 |